header-logo header-logo

10 July 2008 / B Mahendra
Issue: 7329 / Categories: Features , Public
printer mail-detail

Doc brief

MODEL DISCLOSURE
DOLI INCAPAX SETTLED
UNFAIRNESS TO DOCTORS

MODEL DISCLOSURE
As everyone by now is aware, dementias due to Alzheimer’s disease have now become a major public health problem. Some 750,000 patients with these conditions are believed to exist in the country and, as it is an age-related condition, numbers are bound to grow given an ageing population that is also projected. There is no specific treatment available for general use at present.

Some years ago excitement was generated by the news that a group of drugs could help control the progress of the condition by acting on one of the chemicals whose regulation in the brain appears to be associated with the disease process. Even on theoretical neuroscientific grounds the effects of these drugs could have been predicted to be modest but there was much interest—a case of clutching at straws—for otherwise the prognosis would be hopeless. In time, and as expected, only a small group of patients appeared to be benefiting from the use of the drug but there is controversy as to which

If you are not a subscriber, subscribe now to read this content
If you are already a subscriber sign in
...or Register for two weeks' free access to subscriber content

MOVERS & SHAKERS

NLJ Career Profile: Nikki Bowker, Devonshires

NLJ Career Profile: Nikki Bowker, Devonshires

Nikki Bowker, head of litigation and dispute resolution at Devonshires, on career resilience, diversity in law and channelling Elle Woods when the pressure is on

Ellisons—Sarah Osborne

Ellisons—Sarah Osborne

Leasehold enfranchisement specialist joins residential property team

DWF—Chris Air

DWF—Chris Air

Firm strengthens commercial team in Manchester with partner appointment

NEWS
The High Court’s refusal to recognise a prolific sperm donor as a child’s legal parent has highlighted the risks of informal conception arrangements, according to Liam Hurren, associate at Kingsley Napley, in NLJ this week
The Court of Appeal’s decision in Mazur may have settled questions around litigation supervision, but the profession should not simply ‘move on’, argues Jennifer Coupland, CEO of CILEX, in this week's NLJ
A simple phrase like ‘subject to references’ may not protect employers as much as they think. Writing in NLJ this week, Ian Smith, barrister and emeritus professor of employment law at UEA, analyses recent employment cases showing how conditional job offers can still create binding contracts

An engagement ring may symbolise romance, but the courts remain decidedly practical about who keeps it after a split, writes Mark Pawlowski, barrister and professor emeritus of property law at the University of Greenwich, in this week's NLJ

Medical reporting organisation fees have become ‘the final battleground’ in modern costs litigation, says Kris Kilsby, costs lawyer at Peak Costs and council member of the Association of Costs Lawyers, in this week's NLJ
back-to-top-scroll